Effect of oral administration of Methylene Blue MMX tablets on double-stranded DNA damage assessed by γH2AX analysis of colon biopsy samples.
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Methylthioninium chloride-Cosmo (Primary)
- Indications Colon cancer
- Focus Pharmacodynamics
- Sponsors Cosmo Pharmaceuticals
- 07 Jun 2017 Biomarkers information updated
- 31 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTtrials.gov.
- 11 Dec 2014 New trial record